Celldex Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Celldex Therapeutics Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Celldex Therapeutics Inc Strategy Report

  • Understand Celldex Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Celldex Therapeutics Inc: Overview

Select Item

Related keylists

Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops, and commercializes targeted immunotherapy and other biologics for the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodies, antibody drug conjugates (ADCs), protein-based therapeutics, immune system modulators and vaccine for unmet medical needs. Its key products in development include CDX-1140; CDX-527, CDX-0159. It’s products find application in the treatment of various indications such as brain cancer, triple negative breast cancer, lymphoma/leukemia, melanoma, and renal cell carcinoma. It operates a manufacturing facility in Massachusetts, the US, and research laboratories in Massachusetts, New Jersey, and Connecticut. Celldex is headquartered in Hampton, New Jersey, the US.

 Gain a 360-degree view of Celldex Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Celldex Therapeutics Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 53 Frontage Road, Suite 220, Hampton, New Jersey, 08827
Website celldex.com
Telephone 1 908 2007500
No of Employees 160
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange CLDX (NASD)
Revenue (2022) $6.9M 192% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -25.9% (2022 vs 2021)
Market Cap* $2.5B
Net Profit Margin (2022) XYZ 56.9% (2022 vs 2021)
* As of and is in US$
View Celldex Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Celldex Therapeutics Inc premium industry data and analytics

80+

Clinical Trials

Determine Celldex Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

70+

Catalyst Calendar

Proactively evaluate Celldex Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Celldex Therapeutics Inc’s relevant decision makers and contact details.

40+

Pipeline Drugs

Identify which of Celldex Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

10+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline:-
CDX-1140:
CD40/Oncology
XYZ
XYZ
XYZ
Understand Celldex Therapeutics Inc portfolio and identify potential areas for collaboration Understand Celldex Therapeutics Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Celldex Therapeutics Inc F. Hoffmann-La Roche Ltd Merck & Co Inc Pfizer Inc AbbVie Inc
Headquarters United States of America Switzerland United States of America United States of America United States of America
City Hampton Basel Kenilworth New York North Chicago
State/Province New Jersey - New Jersey New York Illinois
No. of Employees 160 103,605 72,000 88,000 50,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Karen L. Shoos Chairman Executive Board 2019 69
Anthony S. Marucci Chief Executive Officer; Director; President Executive Board 2008 61
Sam Martin Chief Financial Officer; Secretary; Senior Vice President Senior Management 2017 52
Diane C. Young, M.D. Senior Vice President; Chief Medical Officer Senior Management 2019 67
Tibor Keler, Ph.D. Chief Scientific Officer; Executive Vice President Senior Management 2008 64
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Celldex Therapeutics Inc key executives to enhance your sales strategy Gain insight into Celldex Therapeutics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward